Company · CIK 0002096997 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Kailera Therapeutics, Inc. · KLRA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
No reported common-stock activity in this period.
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 7, 2026 AForm 4 → | Sep 9, 7:29 pm EDT | Nur NicholsonChief Technology Officer | 220,000 | — | — | 220,000 | — | |
| Jul 6, 2026 AForm 4 → | Jul 8, 4:20 pm EDT | Kathleen TregoningSee Remarks | 175,000 | — | — | 175,000 | — |